Connection

Anand Sharma to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Anand Sharma has written about Radiopharmaceuticals.
Anand Sharma
Connection Strength
0.713
Radiopharmaceuticals
  1. Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity. Anticancer Res. 2018 Sep; 38(9):5423-5427.
    View in: PubMed
    Score: 0.600
  2. The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. Urol Oncol. 2022 10; 40(10):434-441.
    View in: PubMed
    Score: 0.049
  3. Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy. J Comput Assist Tomogr. 2018 Jan/Feb; 42(1):146-150.
    View in: PubMed
    Score: 0.036
  4. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.